Piper Jaffray Remains Bullish on Horizon Pharma (HZNP) as Stock Loses Value
Tweet Send to a Friend
Piper Jaffray maintained an Overweight rating and $44.00 price target on Horizon Pharma (NASDAQ: HZNP) after the stock loses over ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
